Followers | 415 |
Posts | 34739 |
Boards Moderated | 1 |
Alias Born | 08/22/2004 |
Tuesday, July 20, 2021 11:04:20 AM
Recent IMNM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2024 11:26:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/19/2024 06:18:49 PM
- Immunome to Present Updated Results for RINGSIDE Phase 2 Trial of AL102 for the Treatment of Desmoid Tumors at the European Society for Medical Oncology (ESMO) Congress 2024 • Business Wire • 09/13/2024 11:00:00 AM
- Immunome to Present at Morgan Stanley 22nd Annual Global Healthcare Conference • Business Wire • 08/29/2024 12:00:00 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/21/2024 08:05:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 01:05:08 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/15/2024 07:21:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 09:54:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 09:51:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 09:48:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 09:43:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 09:40:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 09:36:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:10:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:05:24 PM
- Immunome Reports Second Quarter 2024 Financial Results and Provides Business Update • Business Wire • 08/12/2024 08:01:00 PM
- Immunome Provides Update on Recent Business Development Activity Expected to Expand ADC Capabilities • Business Wire • 07/25/2024 12:00:00 PM
- Immunome Appoints Phil Tsai as Chief Technical Officer • Business Wire • 06/27/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:08:29 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:05:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:01:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 12:56:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 12:48:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:05:42 PM
- Immunome Announces Completion of Purchase of Assets from Atreca • Business Wire • 05/20/2024 12:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM